|
JP2020151470A
|
|
Walking evaluation device, walking evaluation method, and program
|
|
JP2019034934A
|
|
Peptide type bacterial dipeptidyl peptidase 7 inhibitor
|
|
JP2019111134A
|
|
Control device and assisting system
|
|
JP2016055178A
|
|
Electric stimulation treatment tool
|
|
JP2017031101A
|
|
Biotin direct-binding protein activity regulator
|
|
JP2016054946A
|
|
Novel aqueous liquid embolic composition
|
|
JP2016044124A
|
|
Dna synthase inhibitor, antiinflammatory agent, antiallergic agent, and method for producing compound contained in the same
|
|
JP2015136378A
|
|
Walking assist tool and shoe including the same
|
|
JP2015054842A
|
|
Dna synthase inhibitor
|
|
JP2015010075A
|
|
γ-GLUTAMYL CYCLOTRANSFERASE INHIBITOR
|
|
JP2014185108A
|
|
Compound having anticancer activity
|
|
JP2014162792A
|
|
Mitochondrial function recovery promoter
|
|
JP2014091731A
|
|
Peptide compound from novel somatostatin, and dna polymerase inhibitor, anticancer agent and apoptosis-inducing agent comprising the same
|
|
JP2014037387A
|
|
Therapeutic agent for muscular dystrophy
|
|
JP2013234150A
|
|
Fat cell differentiation inhibitor
|
|
JP2013230988A
|
|
Peptide synthesis method using microwave with low racemization rate
|
|
JP2013203680A
|
|
Vitamin e derivative-containing drug carrier particle with retentivity in blood
|
|
JP2013203679A
|
|
Mmp-1 inhibitor containing ougon extract
|
|
JP2013201899A
|
|
Method for producing buckwheat tofu and buckwheat tofu
|
|
JP2013194046A
|
|
New compound having dna polymerase inhibitory activity
|
